Pandemic non-adjuvanted influenza A H1N1 vaccine in a cohort of patients with systemic sclerosis.

about

Pandemic non-adjuvanted influenza A H1N1 vaccine in a cohort of patients with systemic sclerosis.

Item

http://www.wikidata.org/entity/Q41926425

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Pandemic non-adjuvanted influe ...... ients with systemic sclerosis.

@en

type

Item

label

Pandemic non-adjuvanted influe ...... ients with systemic sclerosis.

@en

prefLabel

Pandemic non-adjuvanted influe ...... ients with systemic sclerosis.

@en

P1476

Pandemic non-adjuvanted influe ...... tients with systemic sclerosis

@en

P2093

Ana C M Ribeiro

http://www.w3.org/2001/XMLSchema#string

Clóvis A Silva

http://www.w3.org/2001/XMLSchema#string

Danieli C O Andrade

http://www.w3.org/2001/XMLSchema#string

Luciana C P Seguro

http://www.w3.org/2001/XMLSchema#string

Maria do Carmo S Timenetsky

http://www.w3.org/2001/XMLSchema#string

Nadia E Aikawa

http://www.w3.org/2001/XMLSchema#string

Percival D Sampaio-Barros

http://www.w3.org/2001/XMLSchema#string

Sandra G Pasoto

http://www.w3.org/2001/XMLSchema#string

Vilma S T Viana

http://www.w3.org/2001/XMLSchema#string

P2860

Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study.

Influenza A/H1N1 vaccination of patients with SLE: can antimalarial drugs restore diminished response under immunosuppressive therapy?

EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR).

EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases.

Systemic sclerosis at the crossroad of polyautoimmunity.

Current frontiers in systemic sclerosis pathogenesis.

Immunogenicity and safety of the 2009 non-adjuvanted influenza A/H1N1 vaccine in a large cohort of autoimmune rheumatic diseases.

The effect of infliximab and timing of vaccination on the humoral response to influenza vaccination in patients with rheumatoid arthritis and ankylosing spondylitis.

Low influenza vaccination rate among patients with systemic sclerosis.

Survival, causes of death, and prognostic factors in systemic sclerosis: analysis of 947 Brazilian patients.

P304

1721-1725

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/RHEUMATOLOGY/KEX330

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Eloisa Bonfa

Alexander Roberto Precioso

P577

2018-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28968874

http://www.w3.org/2001/XMLSchema#string

P921

Arwas